Cereno Scientific AB - Class B

NEW
OSTO:CRNO B (Sweden)   B
kr 5.50 (0%) Dec 13
At Loss
P/B:
7.15
Market Cap:
kr 1.55B ($ 141.16M)
Enterprise V:
kr 1.57B ($ 142.67M)
Volume:
454.88K
Avg Vol (2M):
1.09M
Trade In:
Volume:
454.88K
At Loss
Avg Vol (2M):
1.09M

Business Description

Description
Cereno Scientific AB is developing a pipeline of preventive therapeutics to treat cardiovascular and rare diseases by epigenetic modulation through histone deacetylase inhibition (HDACi). The company's lead program, CS1, is a phase two dual-acting antithrombotic drug aimed at venous thrombosis and stroke prevention for atrial fibrillation. Cereno Scientificalso evaluates the potential of epigenetic modulation for rare diseases related to pulmonary fibrosis, thrombosis, inflammation, and high blood pressure in the pulmonary circulation system.
Name Current Vs Industry Vs History
Cash-To-Debt 0.82
Equity-to-Asset 0.67
Debt-to-Equity 0.39
Debt-to-EBITDA -1.39
Piotroski F-Score 1/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 34.19
9-Day RSI 46.75
14-Day RSI 49.52
3-1 Month Momentum % -16
6-1 Month Momentum % 16.68
12-1 Month Momentum % 6.74

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 3.25
Quick Ratio 3.25
Cash Ratio 3.06

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -48.2
Shareholder Yield % -7.95
Name Current Vs Industry Vs History
ROE % -35.73
ROA % -27.45
ROIC % -28.97
3-Year ROIIC % -18.17
ROC (Joel Greenblatt) % -15242.77
ROCE % -23.94

GF Value Rank

Name Current Vs Industry Vs History
PB Ratio 7.15
EV-to-EBIT -23.95
EV-to-EBITDA -23.99
EV-to-Forward-Revenue 16.63
EV-to-FCF -10.67
Earnings Yield (Greenblatt) % -4.17
FCF Yield % -9.84

Financials (Next Earnings Date:2025-02-25)

OSTO:CRNO B's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Cereno Scientific AB Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil kr)
EPS (TTM) (kr) -0.33
Beta -
3-Year Sharpe Ratio 0.46
3-Year Sortino Ratio 1.14
Volatility % 67.3
14-Day RSI 49.52
14-Day ATR (kr) 0.300653
20-Day SMA (kr) 5.4467
12-1 Month Momentum % 6.74
52-Week Range (kr) 3.405 - 9.5
Shares Outstanding (Mil) 281.7

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 1
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Cereno Scientific AB Filings

Filing Date Document Date Form
No Filing Data

Cereno Scientific AB Stock Events

Financials Calendars
Event Date Price (kr)
No Event Data

Cereno Scientific AB Frequently Asked Questions

What is Cereno Scientific AB(OSTO:CRNO B)'s stock price today?
The current price of OSTO:CRNO B is kr5.50. The 52 week high of OSTO:CRNO B is kr9.50 and 52 week low is kr3.41.
When is next earnings date of Cereno Scientific AB(OSTO:CRNO B)?
The next earnings date of Cereno Scientific AB(OSTO:CRNO B) is 2025-02-25.
Does Cereno Scientific AB(OSTO:CRNO B) pay dividends? If so, how much?
Cereno Scientific AB(OSTO:CRNO B) does not pay dividend.

Press Release

Subject Date
No Press Release